PMC: PharMerica Corporation Instablogs

Quote & Headlines Market Currents StockTalk

All
| Earnings
| Dividends
| M&A
| On the move

Wednesday, May 1, 5:50 PM PharMerica (PMC): Q1 EPS of $0.46 beats by $0.12. Revenue of $498.9M beats by $66.81M. (PR) Comment! [Earnings, Breaking News]
Tuesday, April 16, 5:48 PM Amgen (AMGN) has agreed to to pay $24.9M to settle allegations that it violated the False Claims Act by paying kickbacks to long-term care pharmacy providers to entice them to use its Aranesp anemia drug instead of a rival medicine. The DoJ claims the payments were made to Omnicare (OCR), PharMerica (PMC) and Kindred Healthcare (KND) in return for implementing "therapeutic interchange" programs that were designed to switch Medicare and Medicaid beneficiaries from a competitor drug to AMGN's Aranesp. Comment! [Healthcare]
Friday, April 12, 4:16 PM PharMerica (PMC) names David W. Froesel, Jr. as interim Chief Financial Officer, effective immediately. Mr. Froesel, who was CFO of Omnicare from 1996 to 2009, and succeeds Michael J. Culotta, who by mutual agreement with the company, has stepped down to pursue other interests. Shares -1.7% AH. Comment! [Healthcare, On the Move]
Monday, February 11, 12:59 PM PharMerica (PMC -3.3%) dips as RBC Capital cuts the shares to Sector Perform on valuation following last weeks earnings report, saying that the nursing home pharmacy's reached it's $15 price target and coupled with declining sales, it doesn't see any incremental catalysts for growth over the near-term. Comment! [Healthcare, On the Move]
Thursday, February 7, 5:14 PM More on PharMerica (PMC): Q4 beats across the board despite double digit declines in total sales, which were driven in part by higher generic dispensing. Cash flow provided by operating activities jumped by 220% on the dispensing increase, with over 85% of prescriptions now dispensed generically. Comment! [Healthcare, Earnings]
Thursday, February 7, 5:01 PM PharMerica (PMC): Q4 EPS of $0.33 beats by $0.04. Revenue of $433.2M (-12.6% Y/Y) beats by $0.77M. (PR) Comment! [Earnings, Breaking News]
Thursday, December 13, 2012, 4:36 PM PharMerica Corporation (PMC) acquires Amerita, a provider of specialty home infusion services with operations in Tennessee, Texas, Oklahoma, Colorado and Utah, in an all cash transaction. Amerita is a leading provider of specialty infusion services, and the purchase will allow PMC to leverage existing pharmacies and broaden its product offerings. The deal is expected to be moderately accretive to the Company in 2013. Comment! [Healthcare]
Thursday, November 1, 2012, 6:41 PM PharMerica (PMC): Q3 EPS of $0.33 beats by $0.03. Revenue of $442M (-14.8% Y/Y) misses by $4M. (PR) Comment! [Earnings]
Thursday, August 2, 2012, 6:24 PM PharMerica (PMC): Q2 EPS of $0.32 beats by $0.02. Revenue of $458M (-13.8% Y/Y) misses by $30M. (PR) Comment! [Earnings]
Monday, July 2, 2012, 4:27 PM PharMerica (PMC) announces $25M increase to its existing share repurchase program . Shares +2.2% AH. Comment! [Healthcare]
Thursday, May 3, 2012, 2:30 PM PharMerica (PMC +3.7%) moves up after beating Q1 estimates late yesterday. Total revenue actually declined 6.8% Y/Y, but margins were boosted by stronger cash flow. RBC ups the shares to Outperform on the report, citing valuation, better visibility and positive earnings growth. Comment! [Earnings, On the Move, Healthcare]
Wednesday, May 2, 2012, 6:52 PM PharMerica (PMC): Q1 EPS of $0.30 beats by $0.03. Revenue of $499M (-6.8% Y/Y) beats by $6M. Shares +0.4% AH. (PR) Comment! [Earnings]
Tuesday, February 21, 2012, 9:58 AM Omnicare (OCR -0.5%) withdraws its hostile offer for nursing-home pharmacy company PharMerica (PMC -2.6%) a month after federal regulators raised antitrust issues. PMC says it is "pleased" with the decision, believing that the offer undervalued the company; OCR says it will provide an update to strategies on Thursday, when it reports its Q4 results. Comment! [Healthcare, M&A, On the Move]
Thursday, February 9, 2012, 5:52 PM PharMerica (PMC): Q4 EPS of $0.27 beats by $0.06. Revenue of $495.6M (+0.8% Y/Y) misses by $10M. Shares +3.1% AH. (PR) Comment! [Earnings, On the Move]
Monday, January 30, 2012, 10:01 AM Though PharMerica (PMC -12.6%) remains off sharply following the FTC's decision to block Omnicare's (OCR -1.4%) hostile bid, the company says it's pleased with the move. Meanwhile, Barclays and Cowen recommend buying Omnicare on any post-FTC weakness, arguing its fundamentals are sound regardless of whether a merger occurs. Comment! [Healthcare, M&A, On the Move, Quick Ideas]
Monday, January 30, 2012, 9:00 AM Premarket gainers: PBY +25%. GTXI +24%. TNB +23%. AMLN +14%. LCC +7%. ARNA +7%. PTNR +4%.
Losers: CTIC -18%. PMC -14%. DB -6%. ING -5%. BCS -5%. MT -5%. CHU -4%. STD -4%. AKS -3%. DANG -3%. PLX -3%. PT -3%. JASO -3%. KOG -3%. X -3%. ANR -3%. RIG -3%. Comment! [On the Move]

PMC PharMerica Corporation

PMC

PharMerica Corporation